Globe Life Inc. (NYSE:GL) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Globe Life Inc. (NYSE:GL) have earned an average recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $172.00.

Several equities research analysts recently weighed in on GL shares. JPMorgan Chase & Co. boosted their target price on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Wells Fargo & Company increased their price target on Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. TD Cowen reissued a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Evercore set a $157.00 price objective on shares of Globe Life in a research note on Wednesday, February 18th. Finally, Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and set a $168.00 price objective on shares of Globe Life in a report on Thursday, March 26th.

Insider Activity at Globe Life

In related news, Director Mark A. Blinn sold 1,750 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the transaction, the director owned 3,372 shares of the company’s stock, valued at approximately $498,752.52. The trade was a 34.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Edward Hensley sold 712 shares of the stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $142.59, for a total value of $101,524.08. Following the sale, the executive vice president owned 8,580 shares of the company’s stock, valued at approximately $1,223,422.20. The trade was a 7.66% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 82,807 shares of company stock valued at $12,041,286. 1.51% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in shares of Globe Life by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after acquiring an additional 86,349 shares during the last quarter. Invesco Ltd. raised its stake in Globe Life by 2.7% during the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock valued at $552,262,000 after purchasing an additional 102,445 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Globe Life by 2.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,135,861 shares of the company’s stock valued at $298,732,000 after purchasing an additional 59,629 shares during the last quarter. Morgan Stanley boosted its holdings in Globe Life by 7.2% in the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after purchasing an additional 125,567 shares during the period. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in Globe Life by 32.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock valued at $200,734,000 after purchasing an additional 355,399 shares during the period. 81.61% of the stock is owned by institutional investors.

Globe Life Trading Up 1.0%

Globe Life stock opened at $140.61 on Thursday. Globe Life has a one year low of $109.38 and a one year high of $152.71. The company’s fifty day moving average price is $141.49 and its two-hundred day moving average price is $138.79. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market capitalization of $11.03 billion, a price-to-earnings ratio of 9.99 and a beta of 0.47.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The company had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.Globe Life’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the firm earned $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, analysts forecast that Globe Life will post 13.87 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. Globe Life’s dividend payout ratio (DPR) is presently 7.67%.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.